263 related articles for article (PubMed ID: 20600486)
1. Immunization and challenge experiments with a new modified live bovine herpesvirus type 1 marker vaccine prototype adjuvanted with a co-polymer.
Kalthoff D; König P; Trapp S; Beer M
Vaccine; 2010 Aug; 28(36):5871-7. PubMed ID: 20600486
[TBL] [Abstract][Full Text] [Related]
2. A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challenge.
Chowdhury SI; Wei H; Weiss M; Pannhorst K; Paulsen DB
Vaccine; 2014 Sep; 32(39):4909-15. PubMed ID: 25066735
[TBL] [Abstract][Full Text] [Related]
3. Biological characterization of bovine herpesvirus 1 recombinants possessing the vaccine glycoprotein E negative phenotype.
Muylkens B; Meurens F; Schynts F; de Fays K; Pourchet A; Thiry J; Vanderplasschen A; Antoine N; Thiry E
Vet Microbiol; 2006 Mar; 113(3-4):283-91. PubMed ID: 16321480
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.
Campos FS; Dezen D; Antunes DA; Santos HF; Arantes TS; Cenci A; Gomes F; Lima FE; Brito WM; Filho HC; Batista HB; Spilki FR; Franco AC; Rijsewijk FA; Roehe PM
Vet Microbiol; 2011 Feb; 148(1):18-26. PubMed ID: 20828945
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of bovine herpesvirus type 1 by deletion of its glycoprotein G and tk genes and protection against virulent viral challenge.
Zhang M; Fu S; Deng M; Xie Q; Xu H; Liu Z; Hu C; Chen H; Guo A
Vaccine; 2011 Nov; 29(48):8943-50. PubMed ID: 21959327
[TBL] [Abstract][Full Text] [Related]
7. A live attenuated glycoprotein E negative bovine herpesvirus 1 vaccine induces a partial cross-protection against caprine herpesvirus 1 infection in goats.
Thiry J; Tempesta M; Camero M; Tarsitano E; Bellacicco AL; Thiry E; Buonavoglia C
Vet Microbiol; 2006 Mar; 113(3-4):303-8. PubMed ID: 16330168
[TBL] [Abstract][Full Text] [Related]
8. Construction, characterization and immunogenicity of a glycoprotein E negative bovine herpesvirus-1.1 Egyptian strain "Abu-Hammad".
El-Kholy AA; Rady DI; Abdou ER; Elseafy MM; Abdelrahman KA; Soliman H
J Virol Methods; 2013 Dec; 194(1-2):74-81. PubMed ID: 23962750
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a triplex real-time PCR assay for the rapid detection and differentiation of wild-type and glycoprotein E-deleted vaccine strains of Bovine herpesvirus type 1.
Wernike K; Hoffmann B; Kalthoff D; König P; Beer M
J Virol Methods; 2011 Jun; 174(1-2):77-84. PubMed ID: 21458493
[TBL] [Abstract][Full Text] [Related]
10. Recombinant virus-expressed bovine cytokines do not improve efficacy of a bovine herpesvirus 1 marker vaccine strain.
König P; Beer M; Makoschey B; Teifke JP; Polster U; Giesow K; Keil GM
Vaccine; 2003 Dec; 22(2):202-12. PubMed ID: 14615147
[TBL] [Abstract][Full Text] [Related]
11. Intraspecific bovine herpesvirus 1 recombinants carrying glycoprotein E deletion as a vaccine marker are virulent in cattle.
Muylkens B; Meurens F; Schynts F; Farnir F; Pourchet A; Bardiau M; Gogev S; Thiry J; Cuisenaire A; Vanderplasschen A; Thiry E
J Gen Virol; 2006 Aug; 87(Pt 8):2149-2154. PubMed ID: 16847110
[TBL] [Abstract][Full Text] [Related]
12. Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle.
Romera SA; Puntel M; Quattrocchi V; Del Médico Zajac P; Zamorano P; Blanco Viera J; Carrillo C; Chowdhury S; Borca MV; Sadir AM
BMC Vet Res; 2014 Jan; 10():8. PubMed ID: 24401205
[TBL] [Abstract][Full Text] [Related]
13. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene.
Kaashoek MJ; Rijsewijk FA; Ruuls RC; Keil GM; Thiry E; Pastoret PP; Van Oirschot JT
Vaccine; 1998 May; 16(8):802-9. PubMed ID: 9627937
[TBL] [Abstract][Full Text] [Related]
14. Genetic immunisation of cattle against bovine herpesvirus 1: glycoprotein gD confers higher protection than glycoprotein gC or tegument protein VP8.
Toussaint JF; Coen L; Letellier C; Dispas M; Gillet L; Vanderplasschen A; Kerkhofs P
Vet Res; 2005; 36(4):529-44. PubMed ID: 15955279
[TBL] [Abstract][Full Text] [Related]
15. A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice.
Caselli E; Boni M; Di Luca D; Salvatori D; Vita A; Cassai E
Comp Immunol Microbiol Infect Dis; 2005 Mar; 28(2):155-66. PubMed ID: 15582691
[TBL] [Abstract][Full Text] [Related]
16. Bovine herpesvirus 1 VP22 enhances the efficacy of a DNA vaccine in cattle.
Zheng C; Babiuk LA; van Drunen Littel-van den Hurk S
J Virol; 2005 Feb; 79(3):1948-53. PubMed ID: 15650221
[TBL] [Abstract][Full Text] [Related]
17. Bovine herpesvirus-1: evaluation of genetic diversity of subtypes derived from field strains of varied clinical syndromes and their relationship to vaccine strains.
Fulton RW; d'Offay JM; Eberle R; Moeller RB; Campen HV; O'Toole D; Chase C; Miller MM; Sprowls R; Nydam DV
Vaccine; 2015 Jan; 33(4):549-58. PubMed ID: 25454086
[TBL] [Abstract][Full Text] [Related]
18. A live bovine herpesvirus-1 marker vaccine is not shed after intramuscular vaccination.
Makoschey B; Beer M
Berl Munch Tierarztl Wochenschr; 2007; 120(11-12):480-2. PubMed ID: 18085158
[TBL] [Abstract][Full Text] [Related]
19. Recombinant MVA expressing secreted glycoprotein D of BoHV-1 induces systemic and mucosal immunity in animal models.
Ferrer MF; Del Médico Zajac MP; Zanetti FA; Valera AR; Zabal O; Calamante G
Viral Immunol; 2011 Aug; 24(4):331-9. PubMed ID: 21830904
[TBL] [Abstract][Full Text] [Related]
20. A recombinant bovine herpesvirus 5 defective in thymidine kinase and glycoprotein E is immunogenic for calves and confers protection upon homologous challenge and BoHV-1 challenge.
Anziliero D; Santos CM; Brum MC; Weiblen R; Chowdhury SI; Flores EF
Vet Microbiol; 2011 Dec; 154(1-2):14-22. PubMed ID: 22019288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
